Charity: MS treatment is ‘lottery’
May 1, 2013Sales and Marketing MS, lottery, society
Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …
Pfizer sales shrink 9 per cent
April 30, 2013Sales and Marketing Ian Read, Lipitor, Pfizer
Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …
Pfizer and Merck create major diabetes alliance
April 30, 2013Research and Development, Sales and Marketing Merck, Pfizer, diabetes
Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …
AstraZeneca backs online NHS passport tool
April 30, 2013Medical Communications, Sales and Marketing NHS, NIHR, app, medication passport
AstraZeneca has provided support to an NHS partner launching an online tool to help patients keep track of their health …
‘Solid’ start for Novartis
April 30, 2013Sales and Marketing Novartis, Q1, sales
Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …
Evolution Marketing Research hires senior director
April 30, 2013Medical Communications, Research and Development, Sales and Marketing Evolution marketing research, david hooper
Healthcare marketing agency Evolution Marketing Research has appointed David Hooper to the firm as senior director, Research. Hooper brings more …
Sales rise for AbbVie
April 30, 2013Sales and Marketing AbbVie, Abbott
AbbVie has released its first financial results as a standalone company since separating from Abbott as an $18 billion biopharma …
DH acts on private data
April 29, 2013Medical Communications, Sales and Marketing Hunt, NHS, data
The government has promised that patients will not be forced into having their personal health records shared by doctors and …
GSK submits UMEC monotherapy
April 29, 2013Sales and Marketing COPD, EMA, GSK, UMEC
GlaxoSmithKline has put its investigational once-daily medicine umeclidinium bromide (UMEC) up for scrutiny by European regulators for patients with chronic …
CTCA changes leadership
April 29, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTCA
The Cancer Treatment Centers of America (CTCA) network has made a change in its executive leadership with the appointment of …
EMA launches ‘black triangle’ post-marketing scheme
April 28, 2013Sales and Marketing EMA, Post-marketing surveillance, black triangle, pharmacovigilance
The European Medicines Agency has unveiled its new ‘black triangle’ post-marketing surveillance system, and the list of drugs that will …
Pfizer’s Xeljanz rejected in Europe
April 28, 2013Sales and Marketing CHMP, Humira, Pfizer, RA, Xeljanz, rheumatoid arthritis
Pfizer has suffered a major setback with the rejection of its new arthritis drug in Europe.The EMA’s medicines committee the …
Prostate cancer drug Xtandi gets nod
April 26, 2013Sales and Marketing Xtandi, Zytiga, prostate cancer
Astellas and Medivation have received a positive opinion from Europe’s Committee for Medicinal Products for Human Use (CHMP) for Xtandi, …
Zyprexa decline hits Lilly
April 26, 2013Sales and Marketing Q1, lilly, zyprexa
Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …
Stevenage Bioscience Catalyst hires marketing manager
April 26, 2013Medical Communications, Sales and Marketing Stevenage Bioscience Catalyst
Open innovation bioscience campus Stevenage Bioscience Catalyst, has announced the appointment of Miranda Knaggs as Marketing, Sales & Events manager. …
Melanoma breakthrough for Merck
April 26, 2013Research and Development, Sales and Marketing FDA, Merck, lambrolizumab, melanoma
Merck’s pipeline has been given a boost by an FDA decision to designate early-stage investigational drug lambrolizumab as a breakthrough …
Pharma R&D ‘untenable’
April 25, 2013Research and Development, Sales and Marketing GlobalData, R&D
The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …
Boehringer’s online PMCPA breach
April 25, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA
Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …
Navigating Cancer hires VP from InVentiv Health
April 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health, navigating cancer
Cancer support service company Navigating Cancer has appointed Suzanne Greenwood to the firm as vice president, Bio-Pharmaceutical Services. Greenwood has …
US doctors support self-monitoring patients
April 24, 2013Medical Communications, Sales and Marketing Manhattan research, doctors, taking the pulse
A new survey of US doctors has found that most have patients who are measuring their health data themselves, and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
